Skip to main content
. 2022 Sep 11;10(9):2251. doi: 10.3390/biomedicines10092251

Table 1.

Characteristics of the study population.

NAFLD (+) NAFLD (−) p-Value
N 6856 10,721
Male 4127 (60.2%) 3542 (33.0%) <0.001
Age (years) 51.1 ± 11.8 47.5 ± 13.2 <0.001
BMI (kg/m2) 26.0 ± 3.6 22.4 ± 3.0 <0.001
Waist circumference (cm) 87.5 ± 9.9 76.3 ± 9.2 0.007
Fasting glucose (mg/dL) 105.4 ± 23.5 94.9 ± 14.8 <0.001
AST (IU/L) 31.1 ± 18.6 26.9 ± 16.5 <0.001
ALT (IU/L) 34.5 ± 25.1 21.7 ± 16.2 <0.001
Alkaline phosphatase (IU/L) 78.0 ± 22.6 70.0 ± 25.6 0.188
GGT (IU/L) 35.1 ± 33.2 21.4 ± 29.7 <0.001
Total cholesterol (mg/dL) 207.9 ± 14.2 202.0 ± 36.5 <0.001
HDL-cholesterol (mg/dL) 51.9 ± 11.5 61.1 ± 13.4 <0.001
LDL-cholesterol (mg/dL) 134.5 ± 33.0 124.8 ± 29.3 <0.001
Triglycerides (mg/dL) 152.8 ± 74.7 99.6 ± 49.7 <0.001
Current smoker (%) 1172 (18.1%) 994 (9.8%) <0.001
Current exercise (%) 4373 (66.4%) 3041 (70.7%) <0.001
Hypertension (%) 1936 (28.2%) 1543 (14.4%) <0.001
Type 2 mellitus (%) 947 (13.8%) 426 (4.0%) <0.001
Metabolic syndrome (%) 1966 (28.7%) 647 (6.0%) <0.001

Values are presented as the mean ± SD or number (percentage). BMI, body mass index; AST, aspartate aminotransferase; ALT, alanine aminotransferase; GGT, γ-glutamyl transferase.